Home/Filings/4/0001209191-22-039238
4//SEC Filing

DANIELS RONALD J 4

Accession 0001209191-22-039238

CIK 0001743881other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:27 PM ET

Size

10.0 KB

Accession

0001209191-22-039238

Insider Transaction Report

Form 4
Period: 2022-06-22
Transactions
  • Award

    Stock Option (right to buy)

    2022-06-22+104,921104,921 total
    Exercise: $8.45Exp: 2032-06-22Common Stock (104,921 underlying)
Footnotes (1)
  • [F1]1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company.

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother
IncorporatedOntario, Canada

Related Parties

1
  • filerCIK 0001164475

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:27 PM ET
Size
10.0 KB